天邦食品(002124) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥1,639,594,622.68, a decrease of 51.89% compared to ¥3,408,300,974.80 in the same period last year[5] - The net profit attributable to shareholders was -¥673,650,083.21, representing a decline of 444.78% from ¥195,385,721.19 in the previous year[5] - The net cash flow from operating activities was -¥91,557,968.08, a decrease of 111.11% compared to ¥824,409,265.41 in the same period last year[5] - Total operating revenue for the current period was ¥1,639,594,622.68, a decrease of 52.1% compared to ¥3,408,300,974.80 in the previous period[27] - Net profit for the current period was a loss of ¥671,194,899.77, compared to a profit of ¥195,809,901.18 in the previous period, indicating a significant decline[27] - The company incurred a significant asset impairment loss of ¥440,407,411.21 during the current period[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥18,612,454,808.87, an increase of 0.66% from ¥18,491,186,457.13 at the end of the previous year[5] - The company's total liabilities increased to ¥15,572,642,472.06 from ¥14,780,489,303.25, representing a rise of 5.4%[23] - The total equity attributable to shareholders decreased to ¥2,779,699,814.28 from ¥3,453,039,814.79, a decline of 19.5%[23] - The total current assets amount to 4,113,825,698.88 RMB, an increase from 3,998,017,460.45 RMB at the beginning of the year[16] - The total non-current assets are reported at 14,498,629,109.99 RMB, slightly up from 14,493,168,996.68 RMB[19] Cash Flow - Cash flow from operating activities was ¥1,670,330,902.93, down from ¥3,536,490,383.72, a decrease of 52.8%[32] - The company reported a decrease in cash and cash equivalents to 1,175,418,468.32 RMB from 1,870,807,492.47 RMB[16] - The ending balance of cash and cash equivalents decreased to $897.24 million from $2.64 billion, highlighting liquidity challenges[38] - Cash received from operating activities totaled $2.08 billion, down from $4.01 billion, indicating a decline in revenue generation[35] - Cash outflow from financing activities increased to $1.82 billion, compared to $1.11 billion in the previous period, indicating higher financing costs[38] Expenses - Management expenses increased by 49.53% year-on-year, attributed to the expansion of pig farming and slaughtering operations[10] - The company's management expenses increased to ¥294,743,449.00 from ¥197,118,845.93, an increase of 49.4%[27] - Research and development expenses decreased by 72.17% compared to the previous year, due to the reduction of related R&D activities in the vaccine sector[10] - Cash paid for purchasing goods and services was $1.10 billion, a decrease from $2.22 billion, suggesting cost-cutting measures[35] - Cash paid to employees decreased to $378.54 million from $456.50 million, reflecting potential workforce adjustments[35] Shareholder Information - The total number of common shareholders at the end of the reporting period is 81,927[13] - Zhang Banghui holds 21.84% of shares, totaling 401,735,485 shares, with 166,260,000 shares pledged[13] Other Income and Comprehensive Income - Other income increased by 207.08% year-on-year, primarily due to an increase in government subsidies received during the reporting period[10] - Other comprehensive income after tax for the current period was ¥310,082.70, compared to a loss of ¥507,192.71 in the previous period[31] Inventory and Accounts Payable - Inventory has increased to 2,526,880,279.04 RMB from 1,774,319,396.43 RMB, indicating a significant rise in stock levels[16] - Accounts payable increased significantly to 2,724,706,347.02 RMB from 1,734,281,466.52 RMB, reflecting higher operational liabilities[19] Foreign Exchange Impact - The company experienced a foreign exchange impact of -$10,119.81 on cash and cash equivalents, contrasting with a positive impact of $73,336.06 in the previous period[38] Strategic Developments - The company has not disclosed any new strategies or product developments in the current report[13]